Myasthenia gravis and shingles

Introduction. Glucocorticoids (GC) are simultaneously the best and worst medications for patients with myasthenia gravis (MG). Their efficacy cannot be denied based on decades of use in clinical practice and an extensive evidence base of retrospective studies, expert opinion, and several consensus guidelines as well as a limited number of …

Myasthenia gravis and shingles. Background: Life-threatening myasthenic crisis (MC) occurs in 10–20% of the patients with myasthenia gravis (MG). It is important to identify the predictors of progression to MC and prognosis in the patients with MG with acute exacerbations. Objective: This study aimed to explore the predictors of progression to MC in the patients …

Pyridostigmine. The first medicine used for myasthenia gravis is usually a tablet called pyridostigmine, which helps electrical signals travel between the nerves and muscles. It can reduce muscle weakness, but the effect only lasts a few hours so you'll need to take it several times a day. For some people, this is the only medicine they need to ...

Idiopathic achalasia is an archetype esophageal motor disorder, causing significant impairment of eating ability and reducing quality of life. The pathophysiological underpinnings of this condition are loss of esophageal peristalsis and insufficient relaxation of the lower esophageal sphincter (LES). The clinical manifestations include ...Myasthenia gravis (MG) is a chronic autoimmune disease with fluctuating muscle weakness and fatigability. Standard immunomodulatory treatment may fail to achieve sufficient improvement with minimal symptom expression or remission of myasthenic symptoms, despite adequate dosing and duration of treatment. Treatment-resistant MG …Key differences between multiple sclerosis and myasthenia gravis are that the latter often causes muscle weakness, typically in the face, which worsens with activity. MS, meanwhile, involves a ...Myasthenia gravis (MG) is an autoimmune neurological disorder characterized by defective transmission at the neuromuscular junction. The incidence of the disease is 4.1 to 30 cases per million person-years, and the prevalence rate ranges from 150 to 200 cases per million. MG is considered a classic example of antibody-mediated autoimmune disease.Listings 11.11 (Post-polio syndrome), 11.12 (Myasthenia gravis), and 11.22 (Motor neuron disorders other than ALS) include criteria for evaluating bulbar and neuromuscular dysfunction. If your neurological disorder has resulted in a breathing disorder, we may evaluate that condition under the respiratory system, 3.00. G.in myasthenia symptoms is higher with live vaccines. How-ever, Shingrix, a non-live vaccine causing exacerbation of the myasthenia symptoms, has not been reported to date. Herein, we present a case of stable myasthenia gravis that got exacerbated after a single dose of Shingrix vaccination. Case Our patient is a 73-year-old man diagnosed with ...Myasthenia gravis is a rare long-term condition that causes muscle weakness. It most commonly affects the muscles that control the eyes and eyelids, facial expressions, chewing, swallowing and speaking. But it can affect most parts of the body. It can affect people of any age, typically starting in women under 40 and men over 60.4 de abr. de 2023 ... Treatment of acute exacerbations and refractory myasthenia gravis (MG) remains challenging despite advances in immunotherapy. ... herpes zoster.

Objective: To determine the rates and characteristics of MG after vaccination in adults in the USA. Background: There has been reports of Myasthenia gravis (MG) occurring or worsening post vaccination. Design/Methods: Data from Vaccine Adverse Event Reporting System (VAERS) from 1990 to 2017 was used. Adult MG cases ascertained from VAERS were classified into definite or possible MG according ...Mayo Clinic Diagnosis Your health care provider will look at your symptoms and medical history and conduct a physical examination. Your provider might use several tests, including: Neurological examination Your provider may check your neurological health by testing: Reflexes. Muscle strength. Muscle tone. Senses of touch and sight. Coordination.Mar 26, 2022 · When myasthenia gravis occurs as a paraneoplastic syndrome, it is typically associated with cancer of the thymus gland (thymoma). Neuromyotonia. Neuromyotonia — also known as Isaacs' syndrome — is characterized by abnormal impulses in nerve cells outside the brain and spinal cord (peripheral nerve hyperexcitability) that control muscle ... If you’ve ever made gravy, or any sauce or similar food to which a thickening agent is added, you know that it acts quite differently once you take it out of a hot, simmering pot and get it on a plate. Gravy, jams, and many sauces all thick...Around 15% to 20% of people with myasthenia gravis have at least one myasthenic crisis. They can be caused by an infection, stress, surgery, or a reaction to medication. Myasthenia Gravis Causes

Myasthenia gravis is a rare long-term condition that causes muscle weakness. It most commonly affects the muscles that control the eyes and eyelids, facial expressions, chewing, swallowing and speaking. But it can affect most parts of the body. It can affect people of any age, typically starting in women under 40 and men over 60.Jun 10, 2022 · It is caused by varicella zoster, the same virus that causes both chickenpox and shingles, explains the American Academy of Otolaryngology Head and Neck Surgery. It is also rare. According to the ... Dec 17, 2021 · Myasthenia gravis is a chronic autoimmune, neuromuscular disease that causes weakness in the skeletal muscles (also called voluntary muscles) that worsens after periods of activity and improves ... Myasthenia gravis (MG) is an autoimmune disease caused by antibodies against the acetylcholine receptor (AChR), muscle-specific kinase (MuSK) or other AChR-related proteins in the postsynaptic ...Abstract. The diagnosis of autoimmune Myasthenia Gravis (MG) remains clinical and rests on the history and physical findings of fatigable, fluctuating muscle weakness in a specific distribution. Ancillary bedside tests and laboratory methods help confirm the synaptic disorder, define its type and severity, classify MG according to the causative ...

Online health studies degree.

Myasthenia gravis (MG) is an autoimmune disease characterized by muscle weakness and abnormal fatigability due to the antibodies against postsynaptic receptors. Despite the individual discrepancy, patients with MG share common muscle weakness, autoimmune dysfunction, and immunosuppressive treatment, which predispose them to …The disease occurs, for the most part, in the third decade, and is rare before the age of 15, or after 70. In approximately 60 per cent of the patients the disease develops between the ages of 20 and 40. 1 The concept that myasthenia gravis (MG) mainly affects young adults and is uncommon after the age of 50 years was based on clinical experience and supported by epidemiological data.Oct 25, 2022 · INTRODUCTION Myasthenia gravis (MG) is an autoimmune neuromuscular disorder characterized by fluctuating motor weakness involving ocular, bulbar, limb, and/or respiratory muscles. The weakness is due to an antibody-mediated, immunologic attack directed at proteins in the postsynaptic membrane of the neuromuscular junction (acetylcholine ... The hallmark of myasthenia gravis is muscle weakness that worsens after periods of activity and improves after periods of rest. Certain muscles such as those that control eye and eyelid movement, facial expression, chewing, talking, and swallowing are often (but not always) involved in the disorder.Introduction: Myasthenia gravis (MG) is an autoimmune disease, for which the risk of exacerbation after vaccines is debated. The aim of this study is to review the available literature concerning safety and efficacy of vaccines in MG.

Myasthenia gravis is a long term (chronic) condition that causes muscle weakness and fatigue. It’s a rare condition that commonly affects the muscles that control the eyes and eyelids. It can also affect the face, speaking, chewing, swallowing and other parts of the body. It can affect people at any age, but is most often found in women under ... The Besta Neurologic Institute rating scale for Myasthenia Gravis also includes 2 endurance tests: one of the arms and one of the legs, which are similar to the QMGS and measured in seconds. These measures are scored independently, rather than being factored into the total score.Although mycophenolate is not licensed for use in neurological diseases, it is widely used to treat autoimmune diseases such as myasthenia gravis. Mycophenolate ...Myasthenia gravis is a chronic autoimmune disorder that causes muscle weakness and fatigue. This article reviews the current knowledge on the pathophysiology, diagnosis, and management of this condition, as well as the latest research on novel therapies and biomarkers. It also discusses the impact of myasthenia gravis on quality of life and the role of multidisciplinary rehabilitation in ...stress – read some tips to help reduce your stress levels infections – you may be advised to have an annual flu jab and the one-off pneumococcal vaccine, but get advice before having a "live" vaccine, such as the shingles vaccine (live vaccines contain viruses or bacteria …Myasthenia Gravis Exacerbation with Shingrix Vaccine | RRNMF Neuromuscular Journal Home / Archives / Vol. 1 No. 4 (2020) / Clinic Stuff (Case Reports) Myasthenia Gravis Exacerbation with Shingrix Vaccine Lakshmi P. Digala, M.B.B.S. Department of Neurology, University of Missouri Health Care, Columbia, MOMayo Clinic Diagnosis Your health care provider will look at your symptoms and medical history and conduct a physical examination. Your provider might use several tests, including: Neurological examination Your provider may check your neurological health by testing: Reflexes. Muscle strength. Muscle tone. Senses of touch and sight. Coordination.Substances such as mercury, aluminum, dioxin, pesticides, asbestos, trichlorethylene, and many other industrial and environmental toxins have been associated with autoimmunity in both animal and human models. 4 These chemicals can induce oxidative stress, T cell dysregulation, and alterations of immune cell messenger systems. 5, 6.About pyridostigmine. Myasthenia gravis is a condition where your muscles become easily tired and weak. There is a fault in the way nerve messages are passed from your nerves to your muscles. As a consequence, your muscles are not stimulated properly, so do not tighten (contract) well. The muscles around the eyes are commonly affected first.It works by boosting the immune system of people who once had chickenpox. The shingles vaccine is administered in two shots given 2 to 6 months apart. Shingrix is not an mRNA vaccine like the ...

Introduction. Myasthenia gravis (MG) is an autoimmune disorder of neuromuscular junction (NMJ) with a prevalence of 150–250 per million. It is characterized by weakness of skeletal muscles due to damage inflicted to NMJ by autoantibodies directed either against acetylcholine receptors (AchRs) or other functionally related molecules on …

People with myasthenia gravis (MG) have muscle weakness that worsens throughout the day. This autoimmune disease affects the neuromuscular system. Drooping eyelids are often the first sign. Eventually, you may find it difficult to control your neck and limbs. Medications and surgery can help relieve the symptoms of this lifelong illness.Myasthenia gravis status was assessed by the blinded rater, using the MGFA classification, 2 the Myasthenic Muscle score, 13 and the MG Activities of Daily Living scale 14 (eTables 2, 4, and 5 in Supplement 1). Hospitalization, treatment with IVIG or plasmapheresis for an MG exacerbation, and hospitalization for thymectomy were …stress - read some tips to help reduce your stress levels infections - you may be advised to have an annual flu jab and the one-off pneumococcal vaccine, but get advice before having a "live" vaccine, such as the shingles vaccine (live vaccines contain viruses or bacteria that have been weakened)Aug 12, 2022 · The shingles vaccine is administered in two shots given 2 to 6 months apart. Shingrix is not an mRNA vaccine like the COVID-19 shot , but research is now underway on adapting the technology to ... Sep 12, 2012 · Myasthenia gravis (MG) is an autoimmune disorder characterized by weakness in specific muscle groups, especially the ocular and bulbar muscles. Guillain-Barré syndrome (GBS) presents with ascending paralysis and areflexia, often secondary to an infection. Several theories have been proposed regarding the etiology behind GBS, with many studies ... The symptoms of herpes zoster oticus include the following: Severe ear pain. Fluid-filled blisters (vesicles) on the outside of the ear (pinna) and in the ear canal. Temporary or permanent paralysis of one side of the face (similar to Bell palsy. Bell Palsy Bell palsy (a type of facial nerve palsy) is sudden weakness or paralysis of muscles on ...Herpes zoster is characterized by a painful, unilateral vesicular eruption that occurs in a restricted dermatomal distribution. Vaccines are available for prevention of both infections. This topic will address the use of the two vaccines used to prevent herpes zoster. A discussion of the vaccine to prevent varicella (chickenpox) is found elsewhere.Myasthenia gravis is a chronic autoimmune neuromuscular disease characterized by weakness in the muscles that worsens after activity and improves after rest. Affected muscles include those of the eyes, face, throat, neck, and limbs. Common early symptoms of myasthenia gravis include: Drooping of one or both eyelids; Blurred or double vision

Kans logo.

Rotc for nursing.

1. Cunningham A.L. et al. (2016) Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older. N Engl J Med. 15;375(11):1019-32.Myasthenia gravis is an autoimmune disease. This means it is caused by your body’s immune system mistakenly attacking healthy tissue at the junction (meeting) between nerves and muscles. This causes problems in the signals that your nerves send to your muscles. Males and females from all ethnic groups can get myasthenia gravis, but it is most ...Myasthenia gravis (MG) is the prototypical autoimmune disorder caused by specific autoantibodies at the neuromuscular junction. Broad-based immunotherapies, such as corticosteroids, azathioprine, mycophenolate, tacrolimus, and cyclosporine, have been effective in controlling symptoms of myasthenia. While being effective in a majority of …Introduction. Myasthenia gravis (MG) is the most common type of neuromuscular transmission disease and is caused by autoantibodies against acetylcholine receptors (AChRs) in the neuromuscular junction or their adjacent proteins. The incidence and prevalence rates of MG are estimated at 0.3–2.8 and 5.35–35 per 100,000, …Introduction. Myasthenia gravis (MG) is a rare autoimmune condition of the neuromuscular junction characterized by fluctuating muscle weakness [].Frequently, it affects the eye and bulbar muscles and rarely the limbs [].Because of advancement in the diagnosis and treatment, the mortality rate has declined from 40 to 5% even in worst …It is caused by varicella zoster, the same virus that causes both chickenpox and shingles, explains the American Academy of Otolaryngology Head and Neck Surgery. It is also rare. According to the ...MG is the most common disorder of neuromuscular transmission. This topic will discuss the overall treatment of generalized MG. Detailed reviews of chronic immunotherapies for MG and thymectomy for MG are found separately. (See "Chronic immunotherapy for myasthenia gravis" and "Role of thymectomy in patients with myasthenia gravis" .)Amyotrophic lateral sclerosis (ALS) and myasthenia gravis (MG) are different disorders affecting motor neurons and neuromuscular junctions, respectively. ALS is a progressive neurodegenerative disorder involving primarily motor neurons in the cerebral cortex, brain stem, and spinal cord, and it is characterized by muscle weakness …10 de out. de 2023 ... Myasthenia gravis is an autoimmune disease and neuromuscular disorder that attacks the neuromuscular junction. Learn more about myasthenia ... ….

Jun 10, 2022 · It is caused by varicella zoster, the same virus that causes both chickenpox and shingles, explains the American Academy of Otolaryngology Head and Neck Surgery. It is also rare. According to the ... INTRODUCTION — Myasthenia gravis (MG) is an autoimmune neuromuscular disorder characterized by fluctuating motor weakness involving ocular, bulbar, limb, and/or respiratory muscles. The weakness is due to an antibody-mediated, immunologic attack directed at proteins in the postsynaptic membrane of the …Myasthenia Gravis - Learn about the causes, symptoms, diagnosis & treatment from the Merck Manuals - Medical Consumer Version.Sep 9, 2016 · Idiopathic achalasia is an archetype esophageal motor disorder, causing significant impairment of eating ability and reducing quality of life. The pathophysiological underpinnings of this condition are loss of esophageal peristalsis and insufficient relaxation of the lower esophageal sphincter (LES). The clinical manifestations include ... Myasthenia Gravis. It’s a problem with your immune system, called an autoimmune disorder. It prevents your nerves and muscles from “talking” to each other like they should. As a result, the ... Generalized myasthenia gravis (gMG) is a rare, chronic, and debilitating autoimmune disease. Activation of the complement system by autoantibodies against the postsynaptic acetylcholine receptor (AChR) leads to destruction of the postsynaptic membrane and disruption of neuromuscular transmission. This trial evaluated …Abstract. This study aimed to review studies focused on the affective comorbidities associated with myasthenia gravis and to determine the extent to which neuromuscular treatment modalities address non-somatic aspects of autoimmune myasthenia gravis. Depression, anxiety, and emotional hyperactivity can aggravate …In the Mayo Clinic series hyperthyroidism was noted first in 54 per cent of cases; myasthenia gravis occurred earlier in 37 per cent. Only 9 per cent had a simultaneous onset. 4. There are ...Myasthenia gravis (my-us-THEE-nee-uh GRAY-vis) causes muscles under your voluntary control to feel weak and get tired quickly. This happens when the communication between nerves and muscles breaks down. There's no cure for myasthenia gravis. Treatment can help with symptoms. These symptoms can include weakness of arm or leg muscles, double ... Myasthenia gravis and shingles, 1. Introduction. Myasthenia gravis is a rare, clinically heterogeneous, autoimmune disorder of the neuromuscular junction characterized by fatigable weakness of voluntary muscles. The prevalence is estimated to be 8 from 20/100,000. [ 1] Myasthenia gravis causes a variety of clinical symptoms, including weakness of the skeletal muscles., Around 15% to 20% of people with myasthenia gravis have at least one myasthenic crisis. They can be caused by an infection, stress, surgery, or a reaction to medication. Myasthenia Gravis Causes, The pathogenesis of myasthenia gravis is autoimmune, the real etiology, however, remains unknown. Virus has been suggested as an etiological agent of the disease. In this study we present 5 myasthenic patients, whose symptoms began a few weeks after a proven viral infection. The possibility of viral …, Symptoms. While blistering and a red or discolored rash are the most visible symptoms of shingles, they are often not the first to present. You may experience pain or tingling under your skin a ..., The pathogenesis of myasthenia gravis is autoimmune, the real etiology, however, remains unknown. Virus has been suggested as an etiological agent of the disease. In this study we present 5 myasthenic patients, whose symptoms began a few weeks after a proven viral infection. The possibility of viral …, INTRODUCTION Myasthenia gravis (MG) is an autoimmune disorder characterized by fatigable weakness of skeletal muscles. Weakness results from an antibody-mediated immunologic attack directed at acetylcholine receptors (or receptor-associated proteins) in the postsynaptic membrane of the neuromuscular junction., Myasthenia gravis (MG) is an autoimmune disease affecting the neuromuscular junction that manifests in clinical symptoms, such as dyspnea, dysphagia, diplopia, dysarthria, ptosis, and fatigable muscle weakness. ... One patient with concomitant immunosuppressive drugs experienced a moderate AE of shingles. Maximum IgG level …, The disease occurs, for the most part, in the third decade, and is rare before the age of 15, or after 70. In approximately 60 per cent of the patients the disease develops between the ages of 20 and 40. 1 The concept that myasthenia gravis (MG) mainly affects young adults and is uncommon after the age of 50 years was based on clinical experience and supported by epidemiological data., Here, we present a case of a 64-year-old female suffering from a severe form of antibody-positive myasthenia gravis. Under an immunosuppressive regimen with cyclosporine A, she experienced an episode of thoracic herpes zoster followed by intense post-herpetic neuralgia. In order to avoid drug intera …, Myasthenia gravis is a chronic autoimmune, neuromuscular disease that causes weakness in the skeletal muscles (also called voluntary muscles) that worsens after periods of activity and improves ..., Myasthenia gravis (MG) is a long-term neuromuscular junction disease that leads to varying degrees of skeletal muscle weakness. The most commonly affected muscles are those of the eyes, face, and swallowing. It can result in double vision, drooping eyelids, trouble talking, and trouble walking. Onset can be sudden. Those affected often have a …, Myasthenia Gravis. Myasthenia gravis is characterized by episodic muscle weakness and easy fatigability caused by autoantibody- and cell-mediated destruction of acetylcholine receptors. It is more common among young women and older men but may occur in men or women at any age. Symptoms worsen with muscle activity and lessen with rest., Sep 17, 2021 · A recent investigation, exploring the molecular and clinical relationship between childhood-onset myasthenia gravis (CMG) and live-attenuated Japanese encephalitis vaccination (LA-JEV), implicated vaccinations in the development of MG, after excluding genetic factors and viral infection . , Myasthenia gravis has important implications and considerations for pregnancy which should be discussed with women. A counselling summary based on the findings of our study is provided in Figure 3. Women with MG are at increased risk of requiring assisted vaginal delivery or caesarean delivery compared to the general …, Myasthenia gravis (MG) is an autoimmune disease characterized by muscle weakness and abnormal fatigability due to the antibodies against postsynaptic receptors. Despite the individual discrepancy, patients with MG share common muscle weakness, autoimmune dysfunction, and immunosuppressive treatment, which predispose them to infections that can trigger or exacerbate MG. Vaccination, as a ..., Jul 12, 2013 · The incidence of shingles in England and Wales is estimated to be around 790 to 880 cases per 100,000 people per year for those aged 70 to 79 years. The risk and severity of shingles increases ... , 28 de jul. de 2016 ... NeuroTalk Support Groups > Health Conditions M - Z > Myasthenia Gravis >. Any need to worry if you have Shingles symptoms? Page 1 of 4, 1, 2 · 3 ..., Myasthenia gravis (MG) is an autoimmune disease where antibodies against the postsynaptic membrane at the neuromuscular junction lead to muscle weakness [ 35 ]. This muscle weakness is generalized in 80% of the patients, being localized to the ocular muscles in only 20%. Respiratory muscles can be involved, and also muscles …, Edrophonium is a reversible acetylcholinesterase inhibitor with rapid onset and short duration of action resulting in an increase of acetylcholine in the neuromuscular junction (NMJ).[1] Since the early 1930s, it has been a diagnostic tool for myasthenia gravis (MG). MG is a neuromuscular disorder characterized by muscular weakness due to …, INTRODUCTION Myasthenia gravis (MG) is an autoimmune neuromuscular disorder characterized by fluctuating motor weakness involving ocular, bulbar, limb, and/or respiratory muscles., This type of myasthenia gravis is called seronegative myasthenia gravis, also known as antibody-negative myasthenia gravis. In general, researchers believe that this type of myasthenia gravis still comes from a problem with autoimmunity, but the antibodies involved just can't be found yet. Thymus gland. The thymus gland is a part of your immune ..., Introduction Myasthenia gravis (MG) is a rare, chronic, autoimmune disease, mediated by immunoglobulin G antibodies, which causes debilitating muscle weakness. As with most rare diseases, there is little patient-reported data with which to understand and address patient needs. This study explores the impact of MG in the real world from the patient …, An enzyme called acetylcholinesterase breaks down acetylcholine. Some drugs that are used to treat myasthenia gravis act on acetylcholinesterase to stop the breakdown of acetylcholine. These acetylcholinesterase inhibitors increase the amount of acetylcholine available and so help muscle activation and contraction., Overview. Vyvgart is a medicine for treating adults with generalised myasthenia gravis (a disease that leads to muscle weakness and tiredness) and whose immune system produce antibodies against a protein called acetylcholine receptor, located on muscle cells. It is given together with other medicines used for the treatment of …, Ocular myasthenia gravis (OMG) is a neuromuscular disease characterized by autoantibody production against post-synaptic proteins in the neuromuscular junction. The pathophysiological auto-immune mechanisms of myasthenia are diverse, and this is governed primarily by the type of autoantibody production. The diagnosis of OMG relies …, The incidence of shingles in England and Wales is estimated to be around 790 to 880 cases per 100,000 people per year for those aged 70 to 79 years. The risk and severity of shingles increases ..., Purpose To determine whether the intravenous administration of low-osmolality contrast material is associated with exacerbation of disease-related symptoms in patients with myasthenia gravis. Materials and Methods This HIPAA-compliant, retrospective cohort study was approved by the institutional review board. The …, With specialized care, patients with myasthenia gravis can have very good outcomes. The mainstays of treatment are acetylcholinesterase inhibitors, and immunosuppressive and immunomodulatory therapies. There is good evidence thymectomy is beneficial in thymomatous and nonthymomatous disease. Nearly all of the drugs used for MG are considered ..., 1. Introduction. Myasthenia gravis (MG) is a common neurologic autoimmune disease, affecting the neuromuscular transmission mediated by antibodies-dependent autoimmunity. The disease is clinically manifested as pathologic fatigability and weakness of affected muscles. In severe cases, dysphagia and/or dyspnea may occur., This updated formal consensus guidance of international MG experts, based on new evidence, provides recommendations to clinicians caring for patients with MG worldwide. Evidence-based recommendations for the treatment of myasthenia gravis (MG) have historically been difficult to develop because of limited evidence from studies with a low risk ..., The incidence of shingles in England and Wales is estimated to be around 790 to 880 cases per 100,000 people per year for those aged 70 to 79 years. The risk and severity of shingles increases ..., Myasthenia gravis (MG) is an autoimmune neuromuscular disorder that is classically characterized by fluctuating weakness and fatigability of the ocular, bulbar, limb, or respiratory muscles. Over half of patients with MG will initially experience isolated ocular symptoms in one or both eyes. Most patients report that ocular symptoms are mild or ..., Myasthenia gravis (MG) is an autoimmune neurological disorder characterized by defective transmission at the neuromuscular junction. The incidence of the disease is 4.1 to 30 cases per million person-years, and the prevalence rate ranges from 150 to 200 cases per million. MG is considered a classic example of antibody-mediated autoimmune ...